コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 L or HIV-1 PTAP L domain was inserted in the viral matrix protein.
2 isition of a host-specific adaptation in the viral matrix protein.
3 force of arenaviral budding and acts as the viral matrix protein.
5 ame detectable, but antibodies against Ebola viral matrix protein 40 (not in the vaccine) were not de
6 RNA genome encodes seven proteins including viral matrix protein 40 (VP40), which is the most abunda
7 inished the ability of Nedd4 to ubiquitinate viral matrix proteins and led to a decrease in the relea
8 structural features commonly associated with viral matrix proteins and that VP24 may have a role in v
9 tase and integrase, decreased amounts of the viral matrix protein, and trace quantities of the viral
10 ther HA (H1, B), neuraminidase (N1, N2, NB), viral matrix proteins, and nucleoproteins were also capt
12 envelope fusogenicity, interaction with the viral matrix protein during assembly, viral infectivity,
14 The nucleocapsid then interacts with the viral matrix protein, leading to specific packaging of t
15 ontents then acidify, causing changes in the viral matrix protein (M1) that coats the inner monolayer
16 luenza A viruses have been attributed to the viral matrix protein (M1), and a number of studies have
18 range of host proteins within VFs, while the viral matrix protein P6 is immobile, as it represents th
20 VLPs rely on the natural properties of the viral matrix protein (VP) 40 to drive budding of filamen
21 in amino acid changes were identified, 1 in viral matrix protein VP40 and 3 in L, the RNA-dependent
22 oose coil can be condensed by binding of the viral matrix protein VP40 to the C terminus of the nucle